NO991160D0 - Sulfatholdige polysaccharider og anvendelser derav ved medisinsk behandling - Google Patents

Sulfatholdige polysaccharider og anvendelser derav ved medisinsk behandling

Info

Publication number
NO991160D0
NO991160D0 NO991160A NO991160A NO991160D0 NO 991160 D0 NO991160 D0 NO 991160D0 NO 991160 A NO991160 A NO 991160A NO 991160 A NO991160 A NO 991160A NO 991160 D0 NO991160 D0 NO 991160D0
Authority
NO
Norway
Prior art keywords
sulfate
applications
medical treatment
containing polysaccharides
polysaccharides
Prior art date
Application number
NO991160A
Other languages
English (en)
Other versions
NO991160L (no
Inventor
Michael William Grady
Peter John Doyle
Laura Sinclair
Original Assignee
Johnson & Johnson Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Medical Ltd filed Critical Johnson & Johnson Medical Ltd
Publication of NO991160D0 publication Critical patent/NO991160D0/no
Publication of NO991160L publication Critical patent/NO991160L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0084—Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
NO991160A 1996-09-11 1999-03-10 Sulfaterte polysakkarider og anvendelser derav i medisinsk behandling NO991160L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9618958A GB2317182B (en) 1996-09-11 1996-09-11 Sulfated polysaccharides and uses thereof in medical treatment
PCT/GB1997/002477 WO1998011141A1 (en) 1996-09-11 1997-09-10 Sulfated polysaccharides and uses thereof in medical treatment

Publications (2)

Publication Number Publication Date
NO991160D0 true NO991160D0 (no) 1999-03-10
NO991160L NO991160L (no) 1999-05-10

Family

ID=10799755

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991160A NO991160L (no) 1996-09-11 1999-03-10 Sulfaterte polysakkarider og anvendelser derav i medisinsk behandling

Country Status (14)

Country Link
US (1) US20090227537A1 (no)
EP (1) EP0925310B1 (no)
JP (1) JP2001500184A (no)
KR (1) KR20000036061A (no)
AU (1) AU726555B2 (no)
BR (1) BR9711747A (no)
CA (1) CA2265780C (no)
DE (1) DE69702862T2 (no)
DK (1) DK0925310T3 (no)
ES (1) ES2152107T3 (no)
GB (1) GB2317182B (no)
NO (1) NO991160L (no)
PT (1) PT925310E (no)
WO (1) WO1998011141A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD940054A1 (it) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
AU3759100A (en) * 1999-03-24 2000-10-09 B.F. Goodrich Company, The Inhibition of matrix metalloproteinases with polymers and pharmaceutical applications thereof
DE10050870A1 (de) * 2000-10-11 2002-08-01 Knoell Hans Forschung Ev Biokompatibles Verbundmaterial für medizinische Anwendungen
US7988962B2 (en) 2003-12-02 2011-08-02 Universiteit Gent Use of polysulphated alginate in cellular matrices
DE102006024748A1 (de) * 2006-05-26 2007-11-29 Paul Hartmann Ag Proteasen-Inhibitor zur Wundbehandlung
DE102007035322B4 (de) 2007-07-25 2011-11-17 Friedrich-Schiller-Universität Jena Verfahren zur Herstellung wasserlöslicher, niedrig substituierter Cellulosesulfate
BRPI0909849A2 (pt) 2008-04-04 2015-10-06 Univ Utah Res Found éteres semi-sintéticos de glicosaminoglicosanos e métodos para fazê-los e usá-los
IT1397246B1 (it) * 2009-05-14 2013-01-04 Fidia Farmaceutici Nuovi medicamenti ad uso topico a base di acido ialuronico solfatato come agente attivante o inibente l'attivita' citochinica
US9522162B2 (en) 2011-03-23 2016-12-20 University Of Utah Research Foundation Methods for treating or preventing urological inflammation
EP2699626A4 (en) * 2011-04-11 2014-10-29 Univ Massachusetts Medical CHEMICALLY MODIFIED CELLULOSE FIBROUS MESH FOR USE AS TISSUE ENGINEERING SCAFFOLDING
CN103360499B (zh) * 2012-04-11 2017-02-08 厦门大学 一种纤维素硫酸酯的简便合成工艺
CN104277130A (zh) 2013-07-02 2015-01-14 中国科学院上海药物研究所 一种硫酸酯化聚古洛糖酸多糖或其可药用盐及其制备方法和用途
WO2015177379A2 (en) 2014-05-23 2015-11-26 Reponex Pharmaceuticals Aps Compositions for promoting the healing of wounds
EP3848047A1 (en) 2014-07-24 2021-07-14 Reponex Pharmaceuticals APS Compositions comprising granulocyte-macrophage colony-stimulating factor for the treatment of inflammatory bowel disease
WO2018053111A1 (en) 2016-09-15 2018-03-22 University Of Utah Research Foundation In situ gelling compositions for the treatment or prevention of inflammation and tissue damage
CN111228653A (zh) 2018-11-13 2020-06-05 格莱科米拉治疗公司 用电离辐射加强癌症治疗的方法
US11491199B1 (en) 2021-06-09 2022-11-08 King Abdulaziz University Anticoagulation activity of sulfated carboxymethyl cellulose/Azadirachta indica leaf powder-based biocomposites

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1056772A (fr) * 1950-06-23 1954-03-02 Procédé de préparation d'un anticoagulant de synthèse
US3115488A (en) * 1960-02-29 1963-12-24 American Home Prod Alginic acid methyl ester sulfates, preparation and molecular weight fractionation thereof
FR1730M (fr) * 1962-01-17 1963-03-18 Charles Riviere Nouvelle composition de collyre.
JPS4943937B1 (no) * 1970-12-28 1974-11-25
US3709877A (en) * 1972-03-07 1973-01-09 Johnson & Johnson Process for the sulfation of cellulosic ethers
US3804092A (en) * 1973-01-15 1974-04-16 Johnson & Johnson Water dispersible nonwoven fabric
JPS5152484A (en) * 1974-10-18 1976-05-10 Sumitomo Chemical Co Pururanno ryusanesuteru oyobi sono enruino seizohoho
US4500519A (en) * 1978-11-06 1985-02-19 Choay S.A. Mucopolysaccharides having biological properties, preparation and method of use
GB2148901A (en) * 1983-10-04 1985-06-05 Johnson & Johnson Protein/polysaccharide complexes
US4879282A (en) * 1987-03-17 1989-11-07 Saliba Jr Michael J Medical application for heparin and related molecules
JPH02178229A (ja) * 1988-12-28 1990-07-11 Fujirebio Inc 抗ウイルス剤
ITPD940054A1 (it) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
US5997863A (en) * 1994-07-08 1999-12-07 Ibex Technologies R And D, Inc. Attenuation of wound healing processes

Also Published As

Publication number Publication date
DE69702862D1 (de) 2000-09-21
GB2317182A (en) 1998-03-18
DE69702862T2 (de) 2001-02-22
JP2001500184A (ja) 2001-01-09
US20090227537A1 (en) 2009-09-10
CA2265780A1 (en) 1998-03-19
EP0925310A1 (en) 1999-06-30
AU726555B2 (en) 2000-11-09
NO991160L (no) 1999-05-10
PT925310E (pt) 2000-11-30
BR9711747A (pt) 1999-08-24
EP0925310B1 (en) 2000-08-16
AU4131597A (en) 1998-04-02
ES2152107T3 (es) 2001-01-16
KR20000036061A (ko) 2000-06-26
CA2265780C (en) 2006-08-22
DK0925310T3 (da) 2000-11-20
GB2317182B (en) 2000-11-01
WO1998011141A1 (en) 1998-03-19
GB9618958D0 (en) 1996-10-23

Similar Documents

Publication Publication Date Title
NO991160D0 (no) Sulfatholdige polysaccharider og anvendelser derav ved medisinsk behandling
EP0963219A4 (en) MANIPULATIONS OF NITROSING AND OXIDATIVE STRESS IN THE TREATMENT OF A DISEASE
DK0776339T3 (da) MHC-komplekser og anvendelser deraf
NO953991D0 (no) Ultrasomisk og elektro-kirurgisk håndstykke av piezotype
PL312026A1 (en) Crosslinked acid polysaccharides and their application
NO970373L (no) Benzoksazoler og pyridinderivater anvendelige ved behandling av type-II-diabetes
NO983235L (no) Fikstur og protese innbefattende samme
NO20001639D0 (no) Kollodiale borosilikater og anvendelse derav ved papirfremstilling
NO991701D0 (no) HIV og cancer behandling
FI950587A0 (fi) Endotoksiinimyrkytyksen ennaltaehkäisyssä ja hoidossa käyttökelpoisia menetelmiä
NO990070D0 (no) Svovelreduserende bakterie og anvendelse derav i avsvovlingsprosesser
NO980218D0 (no) p16 ekspresjonskonstruksjoner og deres anvendelse i kreftbehandling
NO970582D0 (no) Fremgangsmåte og blandinger nyttige i protylakse og behandling av endotoksin-relaterte tilstander
FI964912A (fi) Parannuksia elintarviketuotteiden valmistamiseen ja siihen liittyen
NO20001412D0 (no) Sammensetninger og fremgangsmåter ved behandling av respiratoriske forstyrrelser
FI964911A0 (fi) Parannuksia elintarviketuotteiden valmistamiseen ja siihen liittyen
NO951825D0 (no) Vannbasert hårbehandlingspreparat og anvendelse av dette
DK0973563T3 (da) System til dialyse og shockbehandling
GB2314273B (en) The use of TCET in the prophylaxis and treatment of allergies
DK0898566T3 (da) Substituerede benzylaminer og anvendelse deraf til behandling af depression
PL332579A1 (en) Application of 1-hydroxy-2-pyridinones in treating dermatological infections
IL127351A0 (en) Combinations comprising VX478 zidovudine FTC and/or 3TC for use in the treatment of HIV
NO972206D0 (no) Bjelke og karosserikonstruksjon
NO964541D0 (no) Porphacyanin og CNC-utvidete porphyriner
PL320922A1 (en) Application of mhc-ii bonding and/or somulating molecules in prevention and/or treatment of diseases involving inflammatory processes

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application